Vascular Solutions (VASC) Tops Q3 EPS by 1c; Issues Solid Outlook

Vascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.31, $0.01 better than the analyst estimate of $0.30. Revenue for the quarter came in at $41.8 million versus the consensus estimate of $41.65 million.

GUIDANCE:

Vascular Solutions sees Q4 2016 EPS of $0.34-$0.36, versus the consensus of $0.35. Vascular Solutions sees Q4 2016 revenue of $43-44 million, versus the consensus of $43.12 million.

Vascular Solutions sees FY2017 EPS of $1.44-$1.48, versus the consensus of $1.45. Vascular Solutions sees FY2017 revenue of $183-187 million, versus the consensus of $181.87 million.

For earnings history and earnings-related data on Vascular Solutions (VASC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c